Evidence-Based Myopia Management
Understanding Myopia Progression and Management
Progressive myopia means that a child's nearsightedness continues to worsen over time, requiring stronger and stronger prescriptions. This progression typically occurs as the eyeball grows longer than normal during childhood and adolescence. The condition is not simply a matter of needing glasses, but rather a structural change in the eye that can have lasting consequences.
Each year, many children see their prescription increase by one or more diopters, a unit of measurement for prescription strength. This makes distant objects increasingly blurry. The earlier myopia begins and the faster it progresses, the higher the final level of nearsightedness is likely to be.
The eye grows rapidly during the school years, and this growth can cause the eyeball to elongate more than it should. In a healthy eye, light focuses directly on the retina, creating a clear image. When the eye becomes too long, light focuses in front of the retina instead, causing distant vision to blur.
Myopia progression tends to be fastest between ages 7 and 12, though it can continue into the late teens or early twenties. Younger children who develop myopia face a longer period of potential progression, which is why early intervention matters.
Higher levels of myopia meaningfully increase the risk of developing serious eye conditions in adulthood. These include retinal detachment, glaucoma, cataracts at a younger age, and myopic macular degeneration, which is damage to the central retina that can occur in people with high myopia. Risk increases with higher myopia and longer axial length, which is the front-to-back measurement of the eye.
- Retinal detachment occurs more frequently because the stretched retina is more fragile
- Glaucoma risk increases substantially in people with high myopia
- Myopic macular degeneration can cause permanent central vision loss
- Cataracts may develop earlier than in people without high myopia
The primary goal of myopia management is to slow the rate at which your child's nearsightedness worsens. By reducing the speed of progression, we aim to keep your child's final prescription lower, which in turn may reduce the lifetime risk of vision-threatening complications. Complete prevention of myopia or reversal of existing myopia is not the objective.
Treatment success is measured by how much we can reduce axial elongation and prescription changes compared to what would have happened without intervention. Even slowing progression by 30 to 50 percent can make a meaningful difference in your child's long-term eye health.
Risk Factors and Warning Signs
Children who develop myopia before age 8 face the greatest risk of high myopia by adulthood because they have more years ahead for progression to occur. The younger your child is when myopia begins, the more urgent it becomes to consider management strategies. Early onset gives the condition more time to worsen.
Conversely, myopia that first appears in the mid to late teens often progresses more slowly and stabilizes sooner. However, any child with progressive myopia deserves evaluation for management options.
If one parent has myopia, a child's risk approximately doubles. When both parents are nearsighted, the risk increases four to six times compared to children whose parents have normal vision. Family history is one of the strongest predictors we consider during evaluation.
Genetics influence not only whether a child will develop myopia, but also how quickly it may progress. We take a thorough family history to assess your child's individual risk profile.
Extended periods of reading, homework, and screen use may contribute to myopia progression, though the exact mechanisms are still being studied. When children focus on close objects for long stretches without breaks, the eye may adapt in ways that encourage elongation. The 20-20-20 rule can help reduce eye strain and improve comfort during near tasks.
- Every 20 minutes, look at something 20 feet away for at least 20 seconds
- Encourage reading and device use at a comfortable distance, not too close
- Ensure adequate lighting to reduce eye strain during near tasks
- Balance homework time with physical activity and outdoor play
Research consistently shows that children who spend more time outdoors have a lower risk of developing myopia and may experience slower progression. Natural daylight appears to play a protective role, possibly through effects on the retina or exposure to distant visual targets. We recommend at least 90 to 120 minutes of outdoor time daily when possible.
This time does not need to involve sports or structured activities. Simply playing, walking, or relaxing outside during daylight hours can be beneficial.
Rapid progression is often identified when a child needs a new, stronger prescription every six to twelve months. Parents may notice their child squinting more often, sitting closer to the television, or complaining that glasses or contact lenses that worked well a few months ago now seem ineffective. Teachers might report that your child has difficulty seeing the board.
- Frequent requests for a new prescription within a year
- Squinting or tilting the head to see distant objects
- Headaches or eye strain after visual tasks
- Loss of interest in activities that require clear distance vision
- Progression of one-half diopter or more per year
Diagnosing and Measuring Myopia Progression
During a myopia evaluation, we go beyond simply measuring your child's prescription for glasses or contact lenses. We assess the overall health of the eye, measure the axial length, and review your child's history of vision changes. The appointment typically lasts longer than a standard eye exam because we gather detailed measurements to establish a baseline. A dilated retinal health evaluation is typically performed as indicated to rule out other conditions.
If we are considering orthokeratology, we may also perform corneal topography to map the shape of the cornea. We also discuss your family history, your child's daily activities, and any symptoms you have noticed. This information helps us understand the full picture of your child's myopia risk and progression pattern.
Axial length refers to the distance from the front to the back of the eye. We measure it using a painless instrument. Optical biometry, which uses light waves, is non-contact and commonly used. Ultrasound may be used in some settings and may involve contact with the eye. As myopia worsens, the axial length increases, so tracking this measurement over time gives us an accurate picture of progression.
Axial length is often a more reliable indicator of myopia progression than prescription alone because it reflects the structural changes happening inside the eye. We use these measurements to monitor how well treatment is working.
Refraction is the test that determines your child's exact prescription. We use a series of lenses and ask your child to compare which options provide the clearest vision. For young children who may have difficulty with subjective responses, we may also use objective methods such as retinoscopy or autorefraction.
- Standard refraction measures the focusing power needed for clear vision
- We record the prescription in diopters for distance and sometimes near vision
- Cycloplegic refraction, using eye drops to relax focusing muscles, is often recommended in children to ensure accurate baseline and progression tracking
- Comparing current and past prescriptions reveals the rate of change
The first comprehensive myopia evaluation serves as the baseline against which we will compare all future measurements. We document the current prescription, axial length, and other relevant findings so we can track even small changes. This baseline allows us to calculate progression rates and adjust treatment plans as needed.
Regular monitoring every three to six months helps us catch acceleration early and confirms that the chosen treatment is having the desired effect.
Myopia Management Treatment Options
MiSight 1 day contact lenses are the first soft contact lenses with an FDA indication specifically to slow myopia progression in children. The labeled initiation age is 8 to 12 years. These daily disposable lenses feature a special dual-focus design that corrects distance vision in the center while creating a treatment zone in the periphery. This design is believed to reduce the signal that encourages the eye to elongate.
Children wear the lenses during waking hours and discard them at the end of each day, eliminating the need for cleaning solutions or storage cases. Clinical studies have shown that MiSight lenses can slow myopia progression by an average of approximately 59 percent over three years compared to single-vision lenses. Candidacy depends on your child's specific prescription range, level of astigmatism, ocular health, and ability to handle lenses. Treatment may continue beyond the initiation age range under clinician direction.
Orthokeratology, often called ortho-k, involves wearing specially designed rigid gas-permeable contact lenses overnight. These lenses gently reshape the cornea while your child sleeps, temporarily correcting myopia so that clear vision is possible during the day without glasses or contacts. Studies suggest that this reshaping effect also appears to slow the progression of myopia.
The FDA has cleared certain ortho-k lenses for overnight wear to temporarily reduce myopia. Slowing myopia progression is an off-label use supported by clinical evidence. Studies suggest ortho-k can reduce myopia progression by 30 to 60 percent. Because the lenses are worn overnight, the risk of microbial keratitis, a serious eye infection, is higher than with daily wear lenses. Strict hygiene and adherence to care instructions are essential to minimize this risk.
- Lenses are worn only at night and removed upon waking
- Children enjoy clear vision throughout the day without corrective eyewear
- The corneal reshaping is reversible when lens wear is discontinued
- Never expose lenses to tap water, swimming pools, hot tubs, or showers
- Clean lenses with the prescribed rub and rinse disinfection system each morning
- Replace the lens storage case regularly as instructed
- Do not wear lenses when ill or if eyes are red or irritated
Low-dose atropine is an eye drop medication used off-label to slow myopia progression. Atropine is FDA-approved for other ophthalmic uses, but its application for myopia control in children is supported by strong clinical evidence rather than a specific FDA indication. The drops are typically compounded at very low concentrations and used nightly.
Common side effects include mild light sensitivity and difficulty focusing up close, though these are less pronounced at lower doses. Atropine may be used alone or in combination with optical treatments when progression remains high. Regular monitoring is required to assess effectiveness and adjust the dose as needed. Treatment decisions are individualized based on your child's progression rate, age, and tolerance.
Certain eyeglass lens designs incorporate special optics intended to slow myopia progression while providing clear central vision. These lenses work by altering the way light focuses at the periphery of the retina. Clinical evidence supports their use, though regulatory status and commercial availability vary by market and manufacturer.
Spectacle lenses may be an option for children who are not candidates for contact lenses or prefer glasses. Compliance is generally simpler than with contact lenses, as the child wears glasses as they would normally. We can discuss whether myopia-control spectacle lenses are available and appropriate for your child during the evaluation.
Choosing the right treatment depends on several factors, including your child's age, prescription, eye health, lifestyle, and maturity level. Some children adapt easily to inserting and removing soft daytime lenses, while others prefer the idea of wearing lenses only at night. We also consider your family's ability to support the daily care routines and attend follow-up appointments.
Certain conditions may make a child unsuitable for contact lens wear, such as significant ocular surface disease, chronic allergic conjunctivitis, recurrent styes or blepharitis, poor hygiene habits, or corneal irregularity. During the consultation, we review the pros and cons of each option in the context of your child's specific needs. There is no single best treatment for everyone, and our goal is to identify the approach most likely to succeed for your family. In some cases, we may recommend combining treatments if progression remains high with a single modality.
What to Expect During Myopia Management Treatment
Once we select a treatment, we provide detailed training on how to insert, remove, and care for lenses if a contact lens option is chosen. For soft daily disposable lenses, the process is straightforward, and most children master it within a few practice sessions. Ortho-k lenses require more instruction because the lenses are rigid and must be handled carefully. For atropine drops, we demonstrate proper instillation technique.
We schedule an initial follow-up visit soon after your child begins treatment to check the fit if using lenses, assess comfort, and confirm that your child or family is handling the treatment correctly. This visit is an opportunity to address any questions or concerns that arise in the first days or weeks of treatment.
For MiSight or similar daily disposable lenses, your child will insert fresh lenses each morning and discard them at bedtime. Hand washing before handling the lenses is essential to reduce infection risk. No cleaning or storage is needed because each pair is used only once. For ortho-k lenses, the lens must be cleaned each morning after removal and stored in fresh disinfecting solution.
- Always wash and dry hands thoroughly before touching lenses
- Insert lenses with clean fingers, following the technique we demonstrate
- Wear lenses for the recommended number of hours each day
- Never swim, shower, or use hot tubs while wearing contact lenses
- Never rinse lenses or storage cases with tap water
- For ortho-k, use fresh disinfecting solution each time and replace the case regularly
- Remove and discard daily lenses before sleeping; remove ortho-k lenses upon waking
Regular follow-up visits are a critical part of myopia management. We typically see patients one day, one week, and one month after starting treatment, then every three to six months thereafter. At each visit, we measure axial length, update the prescription, check the lens fit if applicable, and examine the eyes for any signs of complications. For ortho-k patients, we closely monitor corneal health with staining checks and repeat topography as needed.
These appointments allow us to confirm that treatment is slowing progression as expected. If progression continues at a faster rate than desired, we may adjust the treatment plan, modify lens parameters, or explore additional strategies.
In the first few days, mild awareness of the lenses, slight dryness, or temporary blurriness is common as your child adapts. These sensations usually resolve within a week. However, persistent pain, redness, sudden vision loss, or discharge from the eye are not normal and require immediate attention.
We encourage you to contact our office if you are unsure whether a symptom is part of the normal adjustment period. It is always safer to ask than to wait and risk a more serious issue.
Myopia management is not a short-term fix but an ongoing treatment that typically continues until your child's prescription stabilizes, often in the late teens or early twenties. Consistency is key to achieving meaningful slowing of progression. Stopping treatment prematurely may allow myopia to resume progressing, though results achieved during treatment are generally maintained.
We work with your family to develop a long-term plan that fits your child's evolving needs, adjusting lens parameters, medication doses, or switching treatments if necessary. The goal is to maintain treatment until natural eye growth slows and myopia stabilizes on its own.
Contact lens wear and other myopia treatments are safe when managed properly, but certain symptoms warrant prompt communication with our office. If your child experiences any red-flag symptoms, remove the contact lens immediately and do not reinsert it until the eye has been evaluated. Contact us the same day for urgent evaluation, and follow any after-hours instructions we have provided for emergency care.
- Persistent or worsening eye pain
- Redness that does not resolve shortly after lens removal
- Sudden blurry vision or vision loss
- Excessive tearing or discharge
- Sensitivity to light that seems abnormal
Frequently Asked Questions
Clinical studies show that evidence-based treatments can reduce myopia progression by an average of 30 to 60 percent compared to children who wear standard glasses or contact lenses. Individual results vary based on factors such as age, initial prescription, compliance with treatment, and genetic predisposition. Slowing progression by even half can significantly reduce the risk of high myopia and associated complications.
No, myopia management treatments are designed to slow the worsening of nearsightedness, not to reverse it or eliminate the need for vision correction altogether. Your child will still require glasses, contact lenses, or other correction to see clearly at a distance. The benefit lies in keeping the final prescription lower than it would otherwise become, which may help protect long-term eye health.
If treatment is discontinued before myopia has naturally stabilized, progression may resume. The degree to which progression resumes varies by individual and treatment type. Some children experience acceleration after stopping, while others continue to stabilize. Any slowing achieved during the treatment period is generally preserved, meaning the eye does not suddenly worsen to catch up with where it would have been. However, to maximize the benefit, we recommend continuing treatment until progression stops on its own. We may also recommend a gradual transition plan and continued monitoring after stopping treatment.
The most common side effects are mild and temporary, such as initial discomfort, dryness, or awareness of the lenses. With atropine, mild light sensitivity and difficulty focusing up close may occur. The most serious risk associated with any contact lens wear is eye infection, which can occur if lenses are not handled with clean hands, exposed to water, or if wearing schedules are not followed. Overnight ortho-k wear carries higher infection risk than daily wear lenses. We minimize these risks through education, proper lens or medication selection, and regular monitoring. Serious complications are rare when patients follow care instructions.
Insurance coverage for myopia management varies widely. Some vision plans are beginning to recognize the long-term value of slowing myopia progression and may offer partial coverage, while others classify it as an elective treatment. We recommend contacting your insurance carrier to ask specifically about coverage for myopia control lenses, atropine treatment, and associated monitoring visits. Our office can provide documentation to support your claim if needed.
Myopia management treatments are most effective in children and adolescents whose eyes are still growing. For most people, the eye finishes growing and myopia stabilizes in the early to mid twenties. However, some individuals in their late teens or early twenties may still experience progression, and treatment can be considered on a case-by-case basis. Adults with stable myopia who wish to reduce their dependence on glasses or contact lenses may explore options such as refractive surgery, but that is a different category of treatment.
Taking the Next Step
If you are concerned about your child's worsening nearsightedness or want to learn whether myopia management is right for your family, we encourage you to schedule a comprehensive myopia evaluation. Our eye doctor will assess your child's individual risk factors, discuss evidence-based treatment options, and help you make an informed decision to support your child's vision health for a lifetime.